Complex neurological phenotype in mutant mice lacking Tsc2 in excitatory neurons of the developing forebrain

eNeuro

Volumn 2, Issue 6, 2015, Pages

  Crowell, Beth ^a   Lee, Gum Hwa ^a,b   Nikolaeva, Ina ^a   Dal Pozzo, Valentina ^a   D’Arcangelo, Gabriella ^a  

^a RUTGERS UNIVERSITY   (United States)

^b Chosun University   (South Korea)

Author keywords

Astrocyte; mTOR; Neuron; Rapamycin; TSC; Tuberous sclerosis complex

Indexed keywords

MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE; TUBERIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; DISEASE MODEL; EPILEPSY; FOREBRAIN; GENETICS; GLIA; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NERVE CELL; NEWBORN; PHENOTYPE; TRANSGENIC MOUSE; TUBEROUS SCLEROSIS;

ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; EPILEPSY; MICE, TRANSGENIC; MULTIPROTEIN COMPLEXES; NEUROGLIA; NEURONS; PHENOTYPE; PROSENCEPHALON; TOR SERINE-THREONINE KINASES; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 85015874121     PISSN: None     EISSN: 23732822     Source Type: Journal    
DOI: 10.1523/ENEURO.0046-15.2015     Document Type: Article

References (37)

1. Bartley CM, O’Keefe RA, Bordey A (2014) FMRP S499 is phosphorylated independent of mTORC1-S6K1 activity. PLoS One 9:e96956. CrossRef Medline
2. Belvindrah R, Graus-Porta D, Goebbels S, Nave KA, Muller U (2007) β1 Integrins in radial glia but not in migrating neurons are essential for the formation of cell layers in the cerebral cortex. J Neurosci 27:13854-13865. CrossRef
3. Carson RP, Van Nielen DL, Winzenburger PA, Ess KC (2012) Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin. Neurobiol Dis 45:369-380. CrossRef Med-line
4. Crino PB (2011) mTOR: a pathogenic signaling pathway in developmental brain malformations. Trends Mol Med 17:734-742. Cross-Ref Medline
5. Crino PB (2013) Evolving neurobiology of tuberous sclerosis complex. Acta Neuropathol 125:317-332. CrossRef Medline
6. Ehninger D, Han S, Shilyansky C, Zhou Y, Li W, Kwiatkowski DJ, Ramesh V, Silva AJ (2008) Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med 14:843-848. CrossRef Medline
7. Feliciano DM, Su T, Lopez J, Platel JC, Bordey A (2011) Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice. J Clin Invest 121:1596-1607. CrossRef Medline
8. Fu C, Cawthon B, Clinkscales W, Bruce A, Winzenburger P, Ess KC (2012) GABAergic interneuron development and function is modulated by the Tsc1 gene. Cereb Cortex 22:2111-2119. CrossRef Medline
9. Fu C, Ess KC (2013) Conditional and domain-specific inactivation of the Tsc2 gene in neural progenitor cells. Genesis 51:284-292. CrossRef Medline
10. Goebbels S, Bode U, Pieper A, Funfschilling U, Schwab MH, Nave KA (2005) Cre/loxP-mediated inactivation of the bHLH transcription factor gene NeuroD/BETA2. Genesis 42:247-252. CrossRef Medline
11. Goorden SM, van Woerden GM, van der Weerd L, Cheadle JP, Elgersma Y (2007) Cognitive deficits in Tsc1+/- mice in the absence of cerebral lesions and seizures. Ann Neurol 62:648-655. CrossRef
12. Goto J, Talos DM, Klein P, Qin W, Chekaluk YI, Anderl S, Malinowska IA, Di Nardo A, Bronson RT, Chan JA, Vinters HV, Kernie SG, Jensen FE, Sahin M, Kwiatkowski DJ (2011) Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proc Natl Acad Sci USA108:E1070–E1079. CrossRef
13. Hernandez O, Way S, McKenna J 3rd, Gambello MJ (2007) Generation of a conditional disruption of the Tsc2 gene. Genesis 45:101-106. CrossRef Medline
14. Huang J, Manning BD (2008) The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 412:179-190. CrossRef Medline
15. Huang J, Manning BD (2009) A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem Soc Trans 37:217-222. CrossRef Medline
16. Kazdoba TM, Sunnen CN, Crowell B, Lee GH, Anderson AE, D’Arcangelo G (2012) Development and characterization of NEX- Pten, a novel forebrain excitatory neuron-specific knockout mouse. Dev Neurosci 34:198-209. CrossRef Medline
17. Laplante M, Sabatini DM (2009) mTOR signaling at a glance. J Cell Sci 122:3589-3594. CrossRef Medline
18. Lipton JO, Sahin M (2014) The neurology of mTOR. Neuron 84:275- 291. CrossRef Medline
19. Ljungberg MC, Sunnen CN, Lugo JN, Anderson AE, D’Arcangelo G (2009) Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis Model Mech 2:389-398. CrossRef Medline
20. Magri L, Cambiaghi M, Cominelli M, Alfaro-Cervello C, Cursi M, Pala M, Bulfone A, Garcìa-Verdugo JM, Leocani L, Minicucci F, Poliani PL, Galli R (2011) Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions. Cell Stem Cell 9:447-462. CrossRef Medline
21. Meikle L, Pollizzi K, Egnor A, Kramvis I, Lane H, Sahin M, Kwiatkowski DJ (2008) Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci 28:5422-5432. CrossRef Medline
22. Meikle L, Talos DM, Onda H, Pollizzi K, Rotenberg A, Sahin M, Jensen FE, Kwiatkowski DJ (2007) A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci 27:5546-5558. CrossRef Medline
23. Mizuguchi M, Takashima S (2001) Neuropathology of tuberous sclerosis. Brain Dev 23:508-515. Medline
24. Sahin M (2012) Targeted treatment trials for tuberous sclerosis and autism: no longer a dream. Curr Opin Neurobiol 22:895-901. CrossRef Medline
25. Sosunov AA, Wu X, Weiner HL, Mikell CB, Goodman RR, Crino PD, McKhann GM 2nd (2008) Tuberous sclerosis: a primary pathology of astrocytes? Epilepsia 49 [Suppl2]:53-62. CrossRef
26. Trotter J, Lee GH, Kazdoba TM, Crowell B, Domogauer J, Mahoney HM, Franco SJ, Müller U, Weeber EJ, D’Arcangelo G (2013) Dab1 is required for synaptic plasticity and associative learning. J Neurosci 33:15652-15668. CrossRef Medline
27. Tsai P, Sahin M (2011) Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex. Curr Opin Neurol 24:106-113. CrossRef Medline
28. Tsai V, Parker WE, Orlova KA, Baybis M, Chi AW, Berg BD, Birnbaum JF, Estevez J, Okochi K, Sarnat HB, Flores-Sarnat L, Aronica E, Crino PB (2014) Fetal brain mTOR signaling activation in tuberous sclerosis complex. Cereb Cortex 24:315-327. CrossRef Medline
29. Tsien JZ, Chen DF, Gerber D, Tom C, Mercer EH, Anderson DJ, Mayford M, Kandel ER, Tonegawa S (1996) Subregion- and cell type-restricted gene knockout in mouse brain. Cell 87:1317-1326. Medline
30. Wang Y, Greenwood JS, Calcagnotto ME, Kirsch HE, Barbaro NM, Baraban SC (2007) Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1. Ann Neurol 61:139-152. CrossRef Medline
31. Way SW, McKenna J 3rd, Mietzsch U, Reith RM, Wu HC, Gambello MJ (2009) Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum Mol Genet 18: 1252-1265. CrossRef Medline
32. Way SW, Rozas NS, Wu HC, McKenna J 3rd, Reith RM, Hashmi SS, Dash PK, Gambello MJ (2012) The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex. Hum Mol Genet 21:3226-3236. CrossRef Medline
33. Wong M, Crino PB (2012) Tuberous sclerosis and epilepsy: role of astrocytes. Glia 60:1244-1250. CrossRef Medline
34. Zeng L-H, Xu L, Gutman DH, Wong M (2008) Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 63:444-453. CrossRef Medline
35. Zeng LH, Rensing NR, Zhang B, Gutmann DH, Gambello MJ, Wong M (2011) Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Hum Mol Genet 20:445-454. CrossRef
36. Zhang L, Bartley CM, Gong X, Hsieh LS, Lin TV, Feliciano DM, Bordey A (2014) MEK-ERK1/2-dependent FLNA overexpression promotes abnormal dendritic patterning in tuberous sclerosis independent of mTOR. Neuron 84:78-91. CrossRef Medline
37. Zhou J, Shrikhande G, Xu J, McKay RM, Burns DK, Johnson JE, Parada LF (2011) Tsc1 mutant neural stem/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle. Genes Dev 25:1595-1600. CrossRef Medline